Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Celal Alandağ

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Anti-Cancer Drugs|March 10, 2022
Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancerCelal Alandağ, Elanur Karaman, Elif Yüce
Anti-Cancer Drugs|June 19, 2021
Repurposing calcium channel blockers: may be sensible combination with erlotinib for non-small cell lung cancerCelal Alandağ, Elif Merev, Feyyaz Özdemir
Archives of Iranian Medicine|December 28, 2020
Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving ChemotherapySami Fidan, Evren Fidan, Celal Alandağ, et al.
Japanese Journal of Clinical Oncology|February 9, 2024
Effects of hormone receptor status on patient clinic and survival in HER2 positive breast cancerMukaddes Yılmaz, Eda Erdiş, Mahmut Uçar, et al.
Rheumatology International|July 13, 2026
Intra-articular VEGF inhibition attenuates cartilage degeneration in a rat model of post-traumatic osteoarthritis: a pilot histopathological studyNeşe Çabuk Çelik, İlker Şen, Nazlı Büyükyıldız, et al.
Cancer Chemotherapy and Pharmacology|December 23, 2024
HER-2 SMASHCelal Alandağ, Ayşegül Öztürk, Fatih Yulak, et al.
Revista Da Associacao Medica Brasileira (1992)|September 22, 2022
The effects of thymoquinone on pancreatic cancer and immune cellsCelal Alandağ, Derya Dilek Kancaği, Gözde Karakuş Sir, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Anti-Cancer Drugs|March 10, 2022
Amlodipine improves the outcomes of regorafenib in metastatic colorectal cancerCelal Alandağ, Elanur Karaman, Elif Yüce
Anti-Cancer Drugs|June 19, 2021
Repurposing calcium channel blockers: may be sensible combination with erlotinib for non-small cell lung cancerCelal Alandağ, Elif Merev, Feyyaz Özdemir
Archives of Iranian Medicine|December 28, 2020
Hepatitis B Virus Screening and Real Life Data in Patients with Solid Tumor Receiving ChemotherapySami Fidan, Evren Fidan, Celal Alandağ, et al.
Japanese Journal of Clinical Oncology|February 9, 2024
Effects of hormone receptor status on patient clinic and survival in HER2 positive breast cancerMukaddes Yılmaz, Eda Erdiş, Mahmut Uçar, et al.
Rheumatology International|July 13, 2026
Intra-articular VEGF inhibition attenuates cartilage degeneration in a rat model of post-traumatic osteoarthritis: a pilot histopathological studyNeşe Çabuk Çelik, İlker Şen, Nazlı Büyükyıldız, et al.
Cancer Chemotherapy and Pharmacology|December 23, 2024
HER-2 SMASHCelal Alandağ, Ayşegül Öztürk, Fatih Yulak, et al.
Revista Da Associacao Medica Brasileira (1992)|September 22, 2022
The effects of thymoquinone on pancreatic cancer and immune cellsCelal Alandağ, Derya Dilek Kancaği, Gözde Karakuş Sir, et al.
Pageof 1